Kaveh Karimzad, MD
Department of Cardiology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1999 | Shahid Beheshti University of Medical Sciences, Tehran, IRN, MD, Medicine |
Postgraduate Training
| 2011-2012 | Clinical Fellowship, Clinical Cardiac Electrophysiology, University of Texas, Houston, TX |
| 2008-2011 | Clinical Fellowship, Cardiovascular Disease, University of Texas, Houston, TX |
| 2006-2008 | Clinical Residency, Internal Medicine, University of Texas, Houston, TX |
| 2005-2006 | Clinical Internship, Internal Medicine, Louisiana State University, New Orleans, LA |
Board Certifications
| 2013 | American Board of Internal Medicine Clinical Cardiac Electrophysiology |
| 2011 | American Board of Internal Medicine Cardiovascular Disease |
| 2010 | National Board of Echocardiography |
| 2008 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019
Administrative Appointments/Responsibilities
Director of Electrophysiology, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Director of Cardiac Device Clinic, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Military or Other Governmental Service
Medical Practice, Military Service Obligation, Ghazvin, Iran, 1999 - 2001
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Kim JW, Dayah TJ, Javaid A, Monlezun DJ, Balanescu DV, Donisan T, Karimzad K, Hakeem A, Boone DL, Palaskas N, Lopez-Mattei J, Kim PY, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkiolis K, Toutouzas K, Johnson NP, Iliescu CA. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas) 58(7), 2022. e-Pub 2022. PMID: 35888603.
- Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma. Haematologica. e-Pub 2021. PMID: 34758610.
- Karimzad K, Deswal A. In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo. Ann Intern Med 174(6):JC69, 2021. e-Pub 2021. PMID: 34058112.
- Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, Palaskas N, Durand JB, Leung CH, Lopez-Mattei J. QT Prolongation in Cancer Patients. Front Cardiovasc Med 8:613625, 2021. e-Pub 2021. PMID: 33718445.
- Khalil M, Karimzad K, Durand JB, Malek AE, Raad II, Viola GM. Prevention of Cardiac Implantable Electronic Device-Related Infection in Patients With Cancer: The Role of a Comprehensive Prophylactic Bundle Approach That Includes the Antimicrobial Mesh. Open Forum Infect Dis 7(11):ofaa433, 2020. e-Pub 2020. PMID: 33204750.
- Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Karimzad K, Kim P, Charitakis K, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin 37(4):469-486, 2019. PMID: 31587788.
- Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2018. PMID: 30543051.
- Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
- Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med 5:48, 2018. e-Pub 2018. PMID: 29868614.
- Reddy N, Moudgil R, Lopez-Mattei JC, Karimzad K, Mouhayar EN, Somaiah N, Conley AP, Patel S, Giza DE, Iliescu C. Progressive and Reversible Conduction Disease with Checkpoint Inhibitors. Can J Cardiol Ref. No.: CJC-D-17-00514R2(10):1335.e13-1335.e15, 2017. e-Pub 2017. PMID: 28822650.
- Giza DE, Boccalandro F, Lopez-Mattei J, Iliescu G, Karimzad K, Kim P, Iliescu C. Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med 19(5):37, 2017. PMID: 28425056.
- Munoz E, Iliescu G, Vejpongsa P, Charitakis K, Karimzad K, Lopez-Mattei J, Yusuf SW, Marmagkiolis K, Iliescu C. Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients?. J Am Coll Cardiol 68(10):1143-4, 2016. PMID: 27585514.
- Loghin C, Karimzadehnajar K, Ekeruo IA, Mukerji SS, Memon NB, Kantharia BK. Outcome of pulmonary vein isolation ablation for paroxysmal atrial fibrillation: predictive role of left atrial mechanical dyssynchrony by speckle tracking echocardiography. J Interv Card Electrophysiol 39(1):7-15, 2014. e-Pub 2013. PMID: 24310816.
- Javadi S, Mosaffa N, Karimzadeh K. The Effect of Glycation of Culture Medium on Phagocytic and Respiratory Burst of Peritoneal Macrophages from Balb/C mice. Immunology 1:179-185, 2004.
Book Chapters
- Kim P, Zarifa A, Salih M, Karimzad K. Oncologic Critical Care. In: Arrhythmias in the Cancer Patient. Springer: United States of America.
- Karimzad, K. Common arrhythmias / Device management in patients with Cancer. In: Cancer and Cardiovascular Disease - A Concise Clinical Atlas. Springer International Publishing AG, Cham.